BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 14269253)

  • 1. NEUTRALIZATION OF THE ADENOVIRUSES TYPES 1 TO 28: SPECIFICITY AND ANTIGENIC RELATIONSHIPS.
    WIGAND R; BAUER H; LANG F; ADAM W
    Arch Gesamte Virusforsch; 1965; 15():188-99. PubMed ID: 14269253
    [No Abstract]   [Full Text] [Related]  

  • 2. REACTIONS BETWEEN ADENOVIRUS ANTIGENS AND PAPAIN DIGESTED RABBIT IMMUNE GLOBULIN.
    KJELLEN L
    Arch Gesamte Virusforsch; 1964; 14():189-200. PubMed ID: 14141579
    [No Abstract]   [Full Text] [Related]  

  • 3. PRODUCTION AND STANDARDIZATION OF ADENOVIRUS TYPES 1 TO 18 REFERENCE ANTISERA.
    RAFAJKO RR
    Am J Hyg; 1964 May; 79():310-9. PubMed ID: 14159950
    [No Abstract]   [Full Text] [Related]  

  • 4. INDUCTION BY ADENOVIRUS TYPE 7 OF TUMORS IN HAMSTERS HAVING THE ANTIGENIC CHARACTERISTICS OF SV40 VIRUS.
    HUEBNER RJ; CHANOCK RM; RUBIN BA; CASEY MJ
    Proc Natl Acad Sci U S A; 1964 Dec; 52(6):1333-40. PubMed ID: 14243505
    [No Abstract]   [Full Text] [Related]  

  • 5. PRODUCTION OF SPECIFIC NEUTRALIZING ANTIBODY WITH SOLUBLE ANTIGENS OF TYPE 5 ADENOVIRUS.
    WILCOX WC; GINSBERG HS
    Proc Soc Exp Biol Med; 1963 Oct; 114():37-42. PubMed ID: 14076907
    [No Abstract]   [Full Text] [Related]  

  • 6. STUDIES ON A COMMON ANTIGEN BETWEEN A1 AND A2 INFLUENZA VIRUSES.
    NISHIKAWA F
    Jpn J Med Sci Biol; 1963 Jun; 16():65-81. PubMed ID: 14048401
    [No Abstract]   [Full Text] [Related]  

  • 7. INFLUENCE OF HEAT INACTIVATION ON THE NEUTRALIZATION OF TYPE 7 ADENOVIRUS BY ANIMAL SERA.
    SVARTZ-MALMBERG G
    Acta Pathol Microbiol Scand; 1964; 60():295-6. PubMed ID: 14121987
    [No Abstract]   [Full Text] [Related]  

  • 8. SERODIFFERENTIATION BETWEEN TYPE 1 POLIOVIRUSES WITH ANTISERA PRODUCED IN RABBITS USING FOUR DIFFERENT IMMUNIZATION SCHEMES.
    SIBONI K; VON MAGNUS
    Acta Pathol Microbiol Scand; 1963; 58():376-84. PubMed ID: 14044676
    [No Abstract]   [Full Text] [Related]  

  • 9. PRODUCTION OF ADENOVIRUS ANTISERUMS IN HORSES.
    LUCAS JB; JOHNSTON JG; KAYE HS; BUCCA MA; ROBINSON RQ
    Public Health Rep (1896); 1965 Jul; 80(7):647-52. PubMed ID: 14310591
    [No Abstract]   [Full Text] [Related]  

  • 10. A COMPARATIVE STUDY OF THE INCIDENCE OF ADENOVIRUS ANTIBODIES IN CHILDREN WITH INTUSSUSCEPTION WITH THAT IN A CONTROL GROUP.
    POTTER CW; SHEDDEN WI; ZACHARY RB
    J Pediatr; 1963 Sep; 63():420-7. PubMed ID: 14061029
    [No Abstract]   [Full Text] [Related]  

  • 11. A STUDY OF THE ANTIGENS INVOLVED IN ADENOVIRUS 12 TUMORIGENESIS BY IMMUNODIFFUSION TECHNIQUES.
    BERMAN LD; ROWE WP
    J Exp Med; 1965 Jun; 121(6):955-67. PubMed ID: 14319410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralization of adenovirus toxins: specificity and antigenic relationships.
    Döring N; Nguyen CX; Wigand R
    Med Microbiol Immunol; 1972; 157(4):325-34. PubMed ID: 4673404
    [No Abstract]   [Full Text] [Related]  

  • 13. PROPERTIES OF TOXOPLASMA LYSATES TOXIC TO RABBITS ON INTRAVENOUS INJECTION.
    LUNDE MN; JACOBS L
    J Parasitol; 1964 Feb; 50():49-51. PubMed ID: 14125168
    [No Abstract]   [Full Text] [Related]  

  • 14. HETEROTYPIC HAEMAGGLUTINATION INHIBITION IN THE ADENOVIRUS GROUP.
    NASZ I; LENGYEL A; DAN P; KULCSAR G
    Acta Microbiol Acad Sci Hung; 1963-1964; 10():379-85. PubMed ID: 14160954
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of adenovirus types 2 and 5 hexons by immunological and biochemical techniques.
    Pereira HG; Laver WG
    J Gen Virol; 1970 Nov; 9(2):163-7. PubMed ID: 4991747
    [No Abstract]   [Full Text] [Related]  

  • 16. The relationship between the soluble antigens and the virion of adenovirus type 3. VI. Further characterization of antigenic sites available at the surface of virions.
    Norrby E; Wadell G
    Virology; 1972 Jun; 48(3):757-65. PubMed ID: 5064085
    [No Abstract]   [Full Text] [Related]  

  • 17. ANTIGENIC SPECIFICITY OF INCLUSION BODIES IN EPIDEMIC KERATOCONJUNCTIVITIS.
    IMRE G; KORCHMAROS I; GECK P; NASZ I; DAN P
    Ophthalmologica; 1964; 148():7-12. PubMed ID: 14185135
    [No Abstract]   [Full Text] [Related]  

  • 18. [ON THE PRESENCE OF COMPLEMENT-BINDING AND NEUTRALIZING ANTIBODIES AGAINST DIFFERENT ADENOVIRUSES].
    DOEHNER L
    Z Immunitats Allergieforsch; 1965 Mar; 128():251-60. PubMed ID: 14307153
    [No Abstract]   [Full Text] [Related]  

  • 19. Avian adenoviruses: a study of 8 field isolates.
    McDougall JS; Peters RW
    Res Vet Sci; 1974 Jan; 16(1):12-8. PubMed ID: 4362257
    [No Abstract]   [Full Text] [Related]  

  • 20. [EXPERIMENTAL DYNAMIC STUDIES ON FORMATION OF ADENOVIRUS HEMAGGLUTININS].
    DIACHENKO NS
    Mikrobiol Zh; 1964; 26():70-5. PubMed ID: 14348373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.